CD33 and diffuse large B-cell lymphoma: observed an increase in M-MDSC (CD14+HLA-DRlow) and G-MDSC (Lin-HLA-DR-CD33+CD11b+) populations in DLBCL patients, however the M-MDSC were the only subset that could be correlated with the International Prognostic Index and event-free survival (33).